The dysfunction in intestinal microorganisms and enzyme activity as significant contributors to diarrhea with

Mengsi Zhou1, Xiaoya Li2, Xuehong Wang3

  • 1College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

Frontiers in Microbiology
|January 24, 2024
PubMed
Abstract

Insights

Diarrhea with kidney-yang deficiency syndrome alters gut microbiota, decreasing beneficial bacteria like Lactobacillus and Bifidobacteria. This study reveals associated changes in intestinal enzyme activity and oxidative stress.

Area of Science:

  • Traditional Chinese Medicine
  • Gastroenterology
  • Microbiology

Background:

  • Diarrhea associated with kidney-yang deficiency syndrome is a complex condition.
  • Understanding its pathogenesis requires examining the interplay between the gut microbiome, enzyme activity, and metabolic markers.

Purpose of the Study:

  • To investigate the pathogenesis of diarrhea with kidney-yang deficiency syndrome.
  • To analyze characteristic changes in intestinal microorganisms, enzyme activities, oxidative stress, and metabolism indices in a mouse model.

Main Methods:

  • A mouse model of diarrhea with kidney-yang deficiency syndrome was established using adenine and Folium sennae decoction.
  • Assessments included microbial culture, enzyme activity assays, malondialdehyde (MDA) and superoxide dismutase (SOD) measurements, and histopathological examination of kidney tissues.

Main Results:

  • The model group showed reduced Lactobacillus and Bifidobacteria, increased overall bacteria and E. coli, and altered intestinal enzyme activities (decreased xylanase, protease; increased amylase, sucrase, lactase).
  • Elevated MDA levels and kidney pathology (tubular dilatation, inflammation) were observed in the model group.
  • Intestinal mucosa microbial activity was diminished.

Conclusions:

  • Dysbiosis in intestinal microorganisms and altered enzyme activities are implicated in the pathogenesis of diarrhea with kidney-yang deficiency syndrome.
  • These findings highlight the role of gut health in this specific syndrome.

Related Concept Videos

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
218
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
120
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.2K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175